Charles Schwab Investment Management Inc. Acquires 21,025 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL)
Charles Schwab Investment Management Inc. raised its holdings in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 1.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,131,485 shares of the biopharmaceutical company’s stock after acquiring an additional 21,025 shares during the period. Charles Schwab […]
Charles Schwab Investment Management Inc. raised its holdings in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) by 1.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,131,485 shares of the biopharmaceutical company’s stock after acquiring an additional 21,025 shares during the period. Charles Schwab […]
